FDA Recalls TRP Natural Eyes Eye Drops Due to Sterility Assurance Issue
The FDA is recalling TRP Natural Eyes Aging Eye Relief eye drops due to lack of assurance of sterility. The affected lot DB001 (expiration 06/24) was distributed to accounts in Rhode Island and Colorado.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of sterile eye drops due to lack of assurance of sterility. While no illnesses or injuries have been reported in the source text, the product poses a potential risk of serious eye infection, qualifying it as a risk-of-harm product where injury has not yet been reported.
Plain-English summary
TRP Natural Eyes, Aging Eye Relief Sterile Eye Drops is being recalled. The product is a homeopathic eye drop in 0.33 FL OZ (10 mL) bottles manufactured by Amman Pharmaceutical Industries in Jordan for TRP Company, Inc. The recalled lot is DB001 with an expiration date of 06/24, affecting 8,747 units.
The FDA has determined the product lacks assurance of sterility. This is a critical concern for ophthalmic products, as lack of sterility can result in contamination and serious eye infections.
The product was distributed to two direct accounts in Rhode Island and Colorado.
Consumers who have this product should discontinue use immediately. Contact TRP Company, Inc. or a healthcare provider if you have questions or concerns about this recall.
The recalled product
- Product
- TRP Natural Eyes, Aging Eye Relief, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502 NDC: 17312-027-15.
- Manufacturer
- AMMAN PHARMACEUTICAL INDUSTRIES
- Category
- Drug — Eye Drops / Ophthalmic
- Hazard
- lack-of-sterility
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot#:DB001 EXP: 06/24
Distribution
Distributed in 2 states:
- CO
- RI
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27